et al., Drug Design, Development and Therapy Bottom line: IGF-1 LR3 is not a hormone disruptor, and it carries very little risk of masculinizing effects
[DOI] [PMC free article] [PubMed] [Google Scholar] 45.Early use of N-acetylcysteine with nitrate therapy in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction reduces myocardial infarct size (the NACIAM trial [N-acetylcysteine in acute myocardial infarction]) Pasupathy S, Tavella R, Grover S, et al
[DOI] [PubMed] [Google Scholar] 37.Clements JA, Heading RC, Nimmo WS, Prescott LF
Kumar 2013), and has been referred to as the number one preventable risk factor for chronic kidney disease(Wickman 2013)
No.: S-COS/10/19
Cekmen M, Ilbey YO, Ozbek E, et al